van Eijkeren Frank J M, Reijmers Ruud S J, Kleinveld Mirjam J, Minten Angret, Bruggen Jan Pieter Ter, Bloem Bastiaan R
Department of Neurology, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands.
Mov Disord. 2008 Nov 15;23(15):2239-43. doi: 10.1002/mds.22293.
Nordic walking may improve mobility in Parkinson's disease (PD). Here, we examined whether the beneficial effects persist after the training period. We included 19 PD patients [14 men; mean age 67.0 years (range 58-76); Hoehn and Yahr stage range 1-3] who received a 6-week Nordic walking exercise program. Outcome was assessed prior to training (T1), immediately after the training period (T2) and-in a subgroup of 9 patients--5 months after training (T3). At T2, we observed a significant improvement in timed 10-m walking, the timed get-up-and-go-test (TUG), the 6-min walking test and quality of life (PDQ-39). All treatment effects persisted at T3. Compliance was excellent, and there were no adverse effects. These preliminary findings suggest that Nordic walking could provide a safe, effective, and enjoyable way to reduce physical inactivity in PD and to improve the quality of life. A large randomized clinical trial now appears justified.
北欧式健走可能改善帕金森病(PD)患者的活动能力。在此,我们研究了训练期结束后这些有益效果是否依然存在。我们纳入了19名帕金森病患者[14名男性;平均年龄67.0岁(范围58 - 76岁);霍恩和亚尔分级范围为1 - 3级],他们接受了为期6周的北欧式健走锻炼计划。在训练前(T1)、训练期结束后立即(T2)以及在9名患者的亚组中训练5个月后(T3)对结果进行评估。在T2时,我们观察到10米定时步行、定时起立行走测试(TUG)、6分钟步行测试以及生活质量(PDQ - 39)有显著改善。所有治疗效果在T3时依然存在。依从性良好,且未出现不良反应。这些初步研究结果表明,北欧式健走可能为减少帕金森病患者的身体活动不足以及改善生活质量提供一种安全、有效且有趣的方式。现在开展一项大型随机临床试验似乎是合理的。